Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...

Multicentre data show microwave ablation offers comparable survival to repeat liver resection for first recurrent ...

French developer Quantum Surgical has scored an FDA clearance for its robot designed specifically to target liver cancer. The company’s Epione system helps plan and perform minimally invasive ablation ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

The global ablation technology market growth is driven by rising cardiovascular and cancer cases, and the increasing adoption ...

Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.

Biologically optimized schedule of gemcitabine and nab-paclitaxel regimen in metastatic pancreatic adenocarcinoma. Background: Pancreatic cancer represents one of the most aggressive tumors and the ...

Cleveland Clinic is the first hospital in the world to use a recently FDA-approved ablation technology that can destroy large liver tumors. The minimally invasive procedure uses a single needle ...

Parenchymal-sparing liver resection with microwave ablation is safe and effective for patients who have neuroendocrine tumors (NETs) and a high number of liver metastases; the treatment has no effect ...